Question 1

Who are the top researchers at GenomiCare (China)?

Accepted Answer

Ranked on the quality score, Jinwang Wei, Guan Wang and Wending Sun lead among researchers whose main affiliation is GenomiCare (China).

Question 2

What are the most cited papers from GenomiCare (China)?

Accepted Answer

The most cited paper from GenomiCare (China) is "Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling" (Xinya Gao, Xin Xia, Fanying Li et al., 2021), with 436 citations. Next come "Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer" (65) and "Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade" (50).

Question 3

Which research topics does GenomiCare (China) publish most on?

Accepted Answer

By volume in 2022-now: Health and Lifestyle Studies, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers and Cancer Genomics and Diagnostics.

Question 4

Which keywords describe research at GenomiCare (China)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Chemotherapy, Tumor Microenvironment, Precision Medicine and Immune Checkpoint Blockade.

Question 5

Which fields of science does GenomiCare (China) work in?

Accepted Answer

In all years, 65% of research at GenomiCare (China) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (30%), Health Professions (3%). It does 2.2× the world's share of Health Sciences.

Question 6

Is GenomiCare (China)'s research output growing?

Accepted Answer

Output in 2022-2025 was 61% lower than in 2018-2021.